On January 8, 2019 Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, reported certain unaudited preliminary fourth quarter 2018 financial results (Press release, Integra LifeSciences, JAN 8, 2019, View Source [SID1234532568]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company expects reported revenue for the fourth quarter of 2018 to be at the higher end of its previous guidance range of $378 million to $383 million. Organic revenue growth in the fourth quarter 2018 is expected to be slightly above 4%.

The company is scheduled to present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019 at 2:30pm PT (5:30pm ET). A live audio webcast of the presentation will be available on the Investor section of the company’s website at www.integralife.com.

The company will report its final, audited fourth quarter and full year 2018 financial results during a conference call in February 2019. A press release with the date, time and webcast information will be provided closer to the reporting date.